Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Thomas Levin Klausen"'
Autor:
Malene Martini Clausen, Esben Andreas Carlsen, Camilla Christensen, Jacob Madsen, Malene Brandt-Larsen, Thomas Levin Klausen, Søren Holm, Annika Loft, Anne Kiil Berthelsen, Niels Kroman, Ulrich Knigge, Andreas Kjaer
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 851 (2022)
Arginine-Glycine-Aspartate (RGD)-recognizing cell surface integrins are involved in tumor growth, invasiveness/metastases, and angiogenesis, and are therefore an attractive treatment target in cancers. The subtype integrin αvβ3 is upregulated on en
Externí odkaz:
https://doaj.org/article/6b3c40f1d8cb46d9923fd8d511068e66
Autor:
Natasha Hemicke Langer, Seppo W. Langer, Helle Hjorth Johannesen, Adam Espe Hansen, Junia Costa, Thomas Levin Klausen, Julie Forman, Anders Olin, Sine Hvid Rasmussen, Jens Benn Sørensen, Johan Löfgren, Andreas Kjær, Barbara Malene Fischer
Publikováno v:
Diagnostics, Vol 9, Iss 1, p 35 (2019)
Purpose: With the increasing number of therapy options available for patients with lung cancer, early response evaluation is needed. We performed this pilot study to assess the feasibility of early, repeated Positron emission tomography-magnetic reso
Externí odkaz:
https://doaj.org/article/851a0dcdb5f7481e94cdb58c19e91b7a
Autor:
Sune Pedersen, Mathilde Ørbæk, Berit Ø Christoffersen, Andreas Vegge, Helle Hjorth Johannesen, Thomas Levin Klausen, Trine Pagh Ludvigsen, Rasmus S. Ripa, Lisbeth H. Olsen, Julie Lyng Forman, Andreas Kjaer, Adam E. Hansen, Johan Löfgren, Rikke Kaae Kirk, Henrik D. Pedersen, Camilla Schumacher-Petersen
Publikováno v:
Atherosclerosis. 285:55-63
Background and aims The advantage of combining molecular and morphological imaging, e.g. positron emission tomography and magnetic resonance imaging (PET/MRI), is reflected in the increased use of these modalities as surrogate end-points in clinical
Autor:
Andreas Kjaer, Martin Hansen, Thomas Levin Klausen, Annika Loft, Adam E. Hansen, Jens J. Holst, Maria S. Svane, Johan Löfgren, Sune H. Keller, Carolyn F. Deacon, Bolette Hartmann, Helle Hjorth Johannesen, Christoffer Martinussen, Sten Madsbad, Nicolai J. Wewer Albrechtsen, Kirstine N. Bojsen-Møller
Publikováno v:
Diabetes. 69
Plasma concentrations of the two pancreatic enzymes, amylase and lipase, are increased within the normal physiological range after initiation of glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment. An association between the use of GLR-1RA a
Autor:
Johan Löfgren, Maria S. Svane, Christoffer Martinussen, Andreas Kjaer, Bolette Hartmann, Helle Hjorth Johannesen, Nicolai J. Wewer Albrechtsen, Thomas Levin Klausen, Adam E. Hansen, Sune H. Keller, Jens J. Holst, Martin Hansen, Annika Loft, Carolyn F. Deacon, Sten Madsbad, Kirstine N. Bojsen-Møller
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 22(10)
AIM To investigate the effect of a glucagon-like peptide-1 receptor agonist (GLP-1RA), liraglutide, on pancreatic volume, oedema, cellularity and DNA synthesis in humans. MATERIALS AND METHODS We performed an open-label study in 14 obese men (age 38
Autor:
Jan Henrik Ardenkjær-Larsen, Annemarie T. Kristensen, Helle Hjorth Johannesen, Henrik Gutte, Pernille Holst, Andreas Clemmensen, Christina Schøier, Andreas Kjaer, Adam E. Hansen, Majbritt M.E. Larsen, Sofie Rahbek, Thomas Levin Klausen
Publikováno v:
Hansen, A E, Gutte, H, Holst, P, Johannesen, H H, Rahbek, S, Clemmensen, A E, Larsen, M M E, Schøier, C, Ardenkjær-Larsen, J H, Klausen, T L, Kristensen, A T & Kjær, A 2018, ' Combined Hyperpolarized 13 C-pyruvate MRS and 18 F-FDG PET (HyperPET) Estimates of Glycolysis in Canine Cancer Patients ', European Journal of Radiology, vol. 103, pp. 6-12 . https://doi.org/10.1016/j.ejrad.2018.02.028
European Journal of Radiology
European Journal of Radiology
13C Magnetic Resonance Spectroscopy (MRS) using hyperpolarized 13C-labeled pyruvate as a substrate offers a measure of pyruvate-lactate interconversion and is thereby a marker of the elevated aerobic glycolysis (Warburg effect) generally exhibited by
Autor:
T.-L. Lambine, J.B. Drejøe, H. Kledal, Giedrius Lelkaitis, Linnea Langhans, J.F. Tvedskov, C.M.S. Hassing, Niels Kroman, Thomas Levin Klausen, T.F. Tvedskov
Publikováno v:
European Journal of Surgical Oncology. 44:725-730
Background Radioactive seed localisation (RSL) is a preoperative localisation method using a small titanium seed containing iodine-125. The method is increasingly applied for localising non-palpable lesions in the treatment of breast cancer. We belie
Autor:
Peter Oturai, Thomas Levin Klausen, T.F. Tvedskov, Ilse Vejborg, Niels Kroman, Niels Bentzon, Cemil Benian, Anne Roslind, Linnea Langhans, M.B. Jensen, John E. Hermansen, M-L Talman
Publikováno v:
Cancer Research. 77:S3-08
Background: The current standard method for locating nonpalpable breast lesions is wire guided localization (WGL) despite several methodological difficulties. Radioactive Seed Localization (RSL) has been developed to reduce these difficulties. The ai
Autor:
Camilla L. Christensen, Malene Brandt-Larsen, Niels Kroman, Anne Kiil Berthelsen, Klaus Brasso, Helle Pappot, Andreas Kjaer, Thomas Levin Klausen, Morten Persson, Flemming L. Andersen, Søren Holm, Jacob Madsen, Annika Loft, Liselotte Højgaard, Dorthe Skovgaard
Publikováno v:
J Nucl Med
The overexpression of urokinase-type plasminogen activator receptors (uPARs) represents an established biomarker for aggressiveness in most common malignant diseases, including breast cancer (BC), prostate cancer (PC), and urinary bladder cancer (UBC
Autor:
Julie Lyng Forman, Barbara M. Fischer, S. Rasmussen, Junia Costa, Jens Benn Sørensen, Anders Olin, Thomas Levin Klausen, Helle Hjorth Johannesen, Andreas Kjaer, Johan Löfgren, Natasha Hemicke Langer, Seppo W. Langer, Adam E. Hansen
Publikováno v:
Diagnostics, Vol 9, Iss 1, p 35 (2019)
Diagnostics; Volume 9; Issue 1; Pages: 35
Langer, N H, Langer, S W, Johannesen, H H, Hansen, A E, Costa, J, Klausen, T L, Forman, J, Olin, A, Rasmussen, S H, Sørensen, J B, Löfgren, J, Kjær, A & Fischer, B M 2019, ' Very Early Response Evaluation by PET/MR in Patients with Lung Cancer : Timing and Feasibility ', Diagnostics, vol. 9, no. 1, 35 . https://doi.org/10.3390/diagnostics9010035
Diagnostics
Langer, N H, Langer, S W, Johannesen, H H, Hansen, A E, Costa, J, Klausen, T L, Forman, J, Olin, A, Rasmussen, S H, Sørensen, J B, Löfgren, J, Kjær, A & Fischer, B M 2019, ' Very Early Response Evaluation by PET/MR in Patients with Lung Cancer-Timing and Feasibility ', Diagnostics (Basel, Switzerland), vol. 9, no. 1, 35 . https://doi.org/10.3390/diagnostics9010035
Diagnostics; Volume 9; Issue 1; Pages: 35
Langer, N H, Langer, S W, Johannesen, H H, Hansen, A E, Costa, J, Klausen, T L, Forman, J, Olin, A, Rasmussen, S H, Sørensen, J B, Löfgren, J, Kjær, A & Fischer, B M 2019, ' Very Early Response Evaluation by PET/MR in Patients with Lung Cancer : Timing and Feasibility ', Diagnostics, vol. 9, no. 1, 35 . https://doi.org/10.3390/diagnostics9010035
Diagnostics
Langer, N H, Langer, S W, Johannesen, H H, Hansen, A E, Costa, J, Klausen, T L, Forman, J, Olin, A, Rasmussen, S H, Sørensen, J B, Löfgren, J, Kjær, A & Fischer, B M 2019, ' Very Early Response Evaluation by PET/MR in Patients with Lung Cancer-Timing and Feasibility ', Diagnostics (Basel, Switzerland), vol. 9, no. 1, 35 . https://doi.org/10.3390/diagnostics9010035
Purpose: With the increasing number of therapy options available for patients with lung cancer, early response evaluation is needed. We performed this pilot study to assess the feasibility of early, repeated Positron emission tomography-magnetic reso